MIT-Dana-Farber Team Identifies Cryptic Peptides as Novel Targets for Pancreatic Cancer Therapy

Preclinical research shows engineered T cells targeting tumor-specific peptides slow pancreatic tumor growth and destroy patient-derived organoids.